Zafgen (ZFGN) Won't Comment on 56% Stock Plunge

Zafgen (ZFGN) Sees Green-to-Red Reversal

Zafgen (NASDAQ: ZFGN) gave up early gains and is negative again following the two-day 50%+ plunge in the stock. Shares last traded down 3.4%. The company is not commenting on the plunge.

Zafgen (ZFGN) Ticks Higher Early Following Sharp Drop

Zafgen (NASDAQ: ZFGN) shares are positive in early trading following a 28.9 percent drop on Tuesday. The stock is up around 7 percent.

Shares fell amid speculation that the company was going to cancel an up coming roadshow.

StreetInsider.com reached out... More

Zafgen (ZFGN) Continues Free Fall Into Close Amid Radio Silence

Zafgen (NASDAQ: ZFGN) continues to plunge into the close as investors are expecting the worst with radio silence from the company.

Shares have plunged 52%, including today's 25% drop, after pulling from a non-deal roadshow.

Earlier, RBC Capital analyst Simos Simeonidis... More

Unusual 11 Mid-Day Movers 10/13: (WPP) (NBBC) (LSCC) Higher; (HTWR) (ZFGN) (AIXG) Lower

Wausau Paper Corp. (NYSE: WPP) 39.0% HIGHER; SCA and Wausau Paper Corp. announced that SCA will acquire Wausau Paper for USD 10.25 per share or total consideration of USD 513 million (approximately SEK 4.2 billion) in cash. The boards of directors of both companies have unanimously approved a definitive merger agreement. The merger consideration represents a premium of 40.6% to Wausau Papers closing price on October 12, 2015 and a premium of 11.3% to the Wausau Paper 52 week volume weighted average price. SCA has funding available.

NewBridge Bancorp (Nasdaq: NBBC)... More

Streetinsider.com's Hot Lunchtime Reads 10/13: (TSLA) (TXMD) (FIG) (ACI)

The following is a list of notable articles to help get you through the lunch hour:Fortress Investment Group (FIG) to Shutter Fortress Macro Funds ->... More

RBC Capital Discusses Theoretical Scenarios Following Zafgen's (ZFGN) Plunge

RBC Capital analyst Simos Simeonidis weighed in on Zafgen (NASDAQ: ZFGN) following yesterday's 35% plunge on no news. Simeonidis outlined a number of theoretical scenarios. The firm notes management has not communicated with us or with most investors we spoke with yesterday or today.

Simeonidis said its either A) data or B) something else.

A) Is it data? Is it possible that the company has the data for either the bestPWS or the Phase IIb ZAF-203 severe obesity trial? Possible, not likely (35%).

A1) The bestPWS data: guidance for early... More

Zafgen (ZFGN) Closes Down 35% on Rumors of Road Show Cancellation

Zafgen (NASDAQ: ZFGN) declined 35% Monday amid rumors it canceled its RBC roadshow set for Tuesday and Wednesday. According to Bloomberg, citing a person familiar, no reason was given for the cancellation.